FdaApplication

ANDA 209382

Back to search

Identifiers

Properties

PropertyValue
applicant_namePH HEALTH LTD
application_typeANDA
approval_date2019-09-24

Products (4)

ProductActive ingredientStrengthDosage form
TREPROSTINILTREPROSTINIL5MG/MLINJECTABLE;INTRAVENOUS, SUBCUTANEOUS
TREPROSTINILTREPROSTINIL10MG/MLINJECTABLE;INTRAVENOUS, SUBCUTANEOUS
TREPROSTINILTREPROSTINIL2.5MG/MLINJECTABLE;INTRAVENOUS, SUBCUTANEOUS
TREPROSTINILTREPROSTINIL1MG/MLINJECTABLE;INTRAVENOUS, SUBCUTANEOUS

4 products